Inventor · disambiguated record
Dana T. Aftab
Also filed as: AFTAB DANA T
18 granted patents·23 pending applications·179 citations·filing 2007–2024
95Inventor score
Top patents by PatentIndex Score
41 records- 0195US11724986B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2020·Granted Aug 15, 2023·6 cites·4 claims
- 0294US11433064B2Methods of using c-Met modulatorsEXELIXIS INC·Filed 2020·Granted Sep 6, 2022·6 cites·4 claims
- 0394US10851061B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2019·Granted Dec 1, 2020·8 cites·8 claims
- 0494US10159666B2Dosing of cabozantinib formulationsEXELIXIS INC·Filed 2015·Granted Dec 25, 2018·21 cites·8 claims
- 0593US10736886B2Methods of using c-Met modulatorsEXELIXIS INC·Filed 2019·Granted Aug 11, 2020·11 cites·6 claims
- 0693US9861624B2Method of treating cancerEXELIXIS INC·Filed 2013·Granted Jan 9, 2018·24 cites·3 claims
- 0792US11760726B2Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2021·Granted Sep 19, 2023·2 cites·11 claims
- 0892US10501418B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2015·Granted Dec 10, 2019·12 cites·11 claims
- 0992US10273211B2Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2014·Granted Apr 30, 2019·17 cites·2 claims
- 1092US10166225B2Method for treating osteoporosisEXELIXIS INC·Filed 2012·Granted Jan 1, 2019·23 cites·9 claims
- 1191US11065240B2Drug combinations to treat multiple myelomaEXELIXIS INC·Filed 2015·Granted Jul 20, 2021·6 cites·4 claims
- 1290US11141413B2Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2017·Granted Oct 12, 2021·8 cites·21 claims
- 1388US8642584B2Method of using PI3K and MEK modulatorsAFTAB DANA T·Filed 2012·Granted Feb 4, 2014·22 cites·2 claims
- 1485US2024287002A1Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2024·Application pending·0 cites
- 1583US2024316030A1Method of treating cancer and bone cancer painEXELIXIS INC·Filed 2024·Application pending·0 cites
- 1681US12486233B2Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2023·Granted Dec 2, 2025·0 cites·11 claims
- 1778US8901137B2Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitorsAFTAB DANA T·Filed 2011·Granted Dec 2, 2014·4 cites·1 claims
- 1877US9011863B2Combinations of kinase inhibitors for the treatment of cancerAFTAB DANA T·Filed 2011·Granted Apr 21, 2015·9 cites·9 claims
- 1977US2024350477A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2023·Application pending·0 cites
- 2076US2023181559A1Methods of Using C-Met ModulatorsEXELIXIS INC·Filed 2022·Application pending·0 cites
- 2176US2023149384A1Method of Treating Cancer and Bone Cancer PainEXELIXIS INC·Filed 2022·Application pending·0 cites
- 2273US2022401433A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2022·Application pending·0 cites
- 2372US2021002228A1Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2020·Application pending·0 cites
- 2469US2023045783A9Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2021·Application pending·0 cites
- 2567US11504363B2Method of treating cancer and bone cancer painEXELIXIS INC·Filed 2020·Granted Nov 22, 2022·0 cites·11 claims
- 2664US11116759B2Method of treating cancerEXELIXIS INC·Filed 2018·Granted Sep 14, 2021·0 cites·4 claims
- 2762US2020163954A1Dosing of Cabozantinib FormulationsEXELIXIS INC·Filed 2020·Application pending·0 cites
- 2861US2019218182A1Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2019·Application pending·0 cites
- 2961US2012252840A1Method of Treating CancerAFTAB DANA T·Filed 2012·Application pending·0 cites
- 3060US2016051532A1Method of Treating CancerEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3159US2015196545A1Method of Treating CancerEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3256US2019076420A1Dosing of Cabozantinib FormulationsEXELIXIS INC·Filed 2018·Application pending·0 cites
- 3355US2010075947A1Methods of Using PI3K and MEK ModulatorsEXELIXIS INC·Filed 2007·Application pending·0 cites
- 3454US2014179736A1Method of Treating Cancer and Bone Cancer PainSCHWAB GISELA·Filed 2012·Application pending·0 cites
- 3552US2014100215A1Methods of Using PI3K and MEK ModulatorsEXELIXIS INC·Filed 2013·Application pending·0 cites
- 3651US2014121239A1Method of treating lung adenocarcinomaEXELIXIS INC·Filed 2013·Application pending·0 cites
- 3751US2015238477A1Method of Treating Lung AdenocarcinomaEXELIXIS INC·Filed 2013·Application pending·0 cites
- 3850US2016000772A1Methods of Using C-Met ModulatorsEXELIXIS INC·Filed 2015·Application pending·0 cites
- 3949US2012282179A1Methods of Using C-Met ModulatorsAFTAB DANA T·Filed 2010·Application pending·0 cites
- 4040US2014323522A1Method of Treating CancerEXELIXIS INC·Filed 2012·Application pending·0 cites
- 4132US2017042880A1Method of Treating Lung AdenocarcinomaEXELIXIS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dana T. Aftab files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →